Thank you, Carol and Cathy, for jumping on the phone at such short notice. Enclosed below is the statement discussed on the call, which you are free to share with your members. The Dear HCP letter is available here on OcalivaHCP.com.
Intercept is reminding physicians about the proper use of Ocaliva in people with PBC with advanced cirrhosis. As part of its standard monitoring, the company uncovered cases where PBC patients with advanced cirrhosis received doses of Ocaliva that are inconsistent with the recommendations made by the FDA. If you are being treated with Ocaliva and have advanced cirrhosis, it’s important that you talk to your doctor to confirm you are being treated in accordance with the U.S. prescribing information.
Carolyn Sobczyk – Account Director
JPA Health Communications
Washington • Boston • London